Features, symptoms, and neurophysiological findings in stroke associated with hyperhomocysteinemia

S. Evers, H. G. Koch, K. H. Grotemeyer, B. Lange, T. Deufel and E. B. Ringelstein
Department of Neurology, University of Munster, Germany. everss@uni.muenster.de

BACKGROUND: Hyperhomocysteinemia has been shown to be a mild independent risk factor for premature atherosclerosis, and there is evidence of an increased rate of peripheral vascular occlusive disease, myocardial infarction, and stroke. OBJECTIVE: To evaluate clinical, biochemical, and neurophysiological findings in patients with ischemic stroke with and without hyperhomocysteinemia. SUBJECTS: One hundred twenty-five consecutive patients with a history of stroke and 60 healthy control subjects. METHODS: Patients were divided into those with and those without hyperhomocysteinemia, which was defined as blood levels beyond the mean total plasma homocysteine level plus 2 SDs of the healthy control group. History, symptoms, cause, patterns of infarction, biochemical data, continuous and transcranial Doppler sonography, and event-related potentials were recorded in all patients. RESULTS: Twenty-seven patients had hyperhomocysteinemia. Compared with the 98 patients without hyperhomocysteinemia, they had an increased rate of hypertension (odds ratio, 3.5; 95% confidence interval, 1.0-12.6), an increased level of uric acid (P < .007), an increased hematocrit (P < .02), a higher rate of microangiopathy (odds ratio, 2.8; 95% confidence interval, 1.1-7.2), and a trend to a higher rate of multiple infarction. Furthermore, the P3 latency of the event-related potential was significantly increased in hyperhomocysteinemia (P < .004). CONCLUSIONS: Hyperhomocysteinemia is probably an independent risk factor for stroke, with a prevalence of about 20% in all patients with a history of stroke; however, additional factors (eg, hypertension, hyperuricemia) may have an enhancing effect. There are significant differences in stroke patterns between patients with and without hyperhomocysteinemia, with a higher rate of lesions typical of cerebral microangiopathy and a trend to multiple infarctions in the former. Impairment of cognitive processing as measured by visual event-related potential is more pronounced in hyperhomocysteinemia.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction
Hassan et al.
Brain 2004;127:212-219.
ABSTRACT | FULL TEXT  

Elevated Plasma Homocysteine Levels in Patients Treated With Levodopa: Association With Vascular Disease
Rogers et al.
Arch Neurol 2003;60:59-64.
ABSTRACT | FULL TEXT  

Homocysteine and Risk of Ischemic Heart Disease and Stroke: A Meta-analysis
Homocysteine Studies Collaboration
JAMA 2002;288:2015-2022.
ABSTRACT | FULL TEXT  

Homocysteine, MTHFR 677C->T polymorphism, and risk of ischemic stroke: Results of a meta-analysis
Kelly et al.
Neurology 2002;59:529-536.
ABSTRACT | FULL TEXT  

Association of Plasma Homocysteine Concentration With Atherosclerotic Carotid Plaques and Lacunar Infarction
Sasaki et al.
Stroke 2002;33:1493-1496.
ABSTRACT | FULL TEXT  

Homocyst(e)ine and cardiovascular disease: a systematic review of the evidence with special emphasis on case-control studies and nested case-control studies
Ford et al.
Int J Epidemiol 2002;31:59-70.
ABSTRACT | FULL TEXT  

Impairment of Cerebrovascular Reactivity by Methionine-Induced Hyperhomocysteinemia and Amelioration by Quinapril Treatment
Chao and Lee
Stroke 2000;31:2907-2911.
ABSTRACT | FULL TEXT  

Homocysteine and Neurologic Disease
Diaz-Arrastia
Arch Neurol 2000;57:1422-1427.
ABSTRACT | FULL TEXT  

Treatment of Atherosclerotic Disease at the Cervical Carotid Bifurcation: Current Status and Review of the Literature
Connors III et al.
Am. J. Neuroradiol. 2000;21:444-450.
FULL TEXT  

Relation of Plasma Homocyst(e)ine to Cerebral Infarction and Cerebral Atherosclerosis
Yoo et al.
Stroke 1998;29:2478-2483.
ABSTRACT | FULL TEXT